Nucleocapsid protein (Nucleocapsid) antibody and antigen (Recombinant protein)

Diagnostic Nucleocapsid protein (Nucleocapsid) antibodies (anti-Nucleocapsid protein, anti-Nucleocapsid) and antigens (recombinant Nucleocapsid protein (Nucleocapsid) protein) for Infectious disease Nucleocapsid detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Infectious disease diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-IVD-P048-Tg001-Ag01 Recombinant human SARS-CoV2 Nucleocapsid Protein $3090.00
GMP-IVD-P048-Tg001-Ab01 Anti-human SARS-CoV2 Nucleocapsid mouse monoclonal antibody (mAb) $1953.00
GMP-IVD-P048-Tg001-Ab02 Anti-human SARS-CoV2 Nucleocapsid mouse monoclonal antibody (mAb) $1953.00
GMP-IVD-P048-Tg001-Ab03 Anti-human SARS-CoV2 Nucleocapsid human monoclonal antibody (mAb) $1953.00
GMP-IVD-P048-Tg001-Ab04 Anti-human SARS-CoV2 Nucleocapsid human monoclonal antibody (mAb) $1953.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Pruducts GMP-IVD-P048-Tg001-Ag01
Product Name Recombinant human SARS-CoV2 Nucleocapsid Protein
Target/Biomarker Nucleocapsid protein (Nucleocapsid)
Alias of Target/Biomarker #N/A
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Nucleocapsid protein (Nucleocapsid) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Nucleocapsid level test of Infectious disease (COVID-19) and related syndrome evaluation
Products description Recombinant human SARS-CoV2 Nucleocapsid Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts GMP-IVD-P048-Tg001-Ab01,GMP-IVD-P048-Tg001-Ab02
Product Name Anti-human SARS-CoV2 Nucleocapsid mouse monoclonal antibody (mAb)
Target/Biomarker Nucleocapsid protein (Nucleocapsid)
Alias of Target/Biomarker #N/A
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation SARS-CoV2 Nucleocapsid protein (Nucleocapsid) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Nucleocapsid protein (Nucleocapsid) antibodies in Nucleocapsid level test of Infectious disease (COVID-19) and related syndrome evaluation.
Tag mFc
Products description Anti-human SARS-CoV2 Nucleocapsid mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Nucleocapsid protein (Nucleocapsid) antibodies.
Reconized/Reactive Species SARS-CoV2
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. of Pruducts GMP-IVD-P048-Tg001-Ab03,GMP-IVD-P048-Tg001-Ab04
Product Name Anti-human SARS-CoV2 Nucleocapsid human monoclonal antibody (mAb)
Target/Biomarker Nucleocapsid protein (Nucleocapsid)
Alias of Target/Biomarker #N/A
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation SARS-CoV2 Nucleocapsid protein (Nucleocapsid) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Nucleocapsid protein (Nucleocapsid) antibodies in Nucleocapsid level test of Infectious disease (COVID-19) and related syndrome evaluation.
Tag hFc
Products description Anti-human SARS-CoV2 Nucleocapsid mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Reconized/Reactive Species SARS-CoV2
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    The nucleocapsids of enveloped RNA viruses are fairly simple structures that contain only one major structural protein, often referred to as the nucleocapsid protein or core protein. This protein is usually quite basic or has a basic domain. It binds to the viral RNA and encapsidates it to form the nucleocapsid. For most RNA viruses, nucleocapsids can be recognized as distinct structures within the infected cell and can be isolated from virions by treatment with detergents that dissolve the envelope. The nucleocapsids of alphaviruses, and probably flaviviruses and arteriviruses as well, are regular icosahedral structures, and there are no other proteins within the nucleocapsid other than the nucleocapsid protein. In contrast, the nucleocapsids of all minus-strand viruses are helical and contain, in addition to the major nucleocapsid protein, two or more minor proteins that possess enzymatic activity. As described, the nucleocapsids of minus-strand RNA viruses remain intact within the cell during the entire infection cycle and serve as machines that make viral RNA. The coronaviruses also have helical nucleocapsids, but being plus-strand RNA viruses they do not need to carry enzymes in the virion to initiate infection. The helical nucleocapsids of (-) RNA viruses appear disordered within the envelope of all viruses except the rhabdoviruses, in which they are coiled in a regular fashion (see later).



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment